Company page

Scholar Rock Holding Corporation

Scholar Rock Holding Corporation, trading under the ticker SRRK, is a public company based in America with a market capitalization of approximately $5.29 billion. The company focuses on developing innovative therapies for serious diseases by targeting the growth factor activation process. Scholar Rock aims to address unmet medical needs through its proprietary drug discovery platform.